Chemotherapeutics: Kinase Inhibitors and Monoclonal Antibodies Flashcards
-tinib suffix for
tyrosine kinase inhibitors
Gefitinib MOA
inhibits tyrosine kinase domain of EGFR
Gefitinib treats
NSCLC
gefitnib side effects
skin rash;acne syndome, diarrhea, anorexia
gefitinib cautions
metabolized by CYP3A4
CYP3A4 inhibited by
grapefruit juice and warfarin
gefitinib unique properties
monotherapy and related drug erlotinib
imatinib MOA
inhibits BCR-Abl kinase (tyrosine kinase)
imatinib treats
CML and GI stormal tumors (GIST)
imatinib side effects
fluid retention/CHF, n/v/d, prolong QT interval, hepatotoxicity, liver metabolism
lapatinib MOA
blocks tyrosine kinase actives of EGFR and HER2/neu
lapatinib treats
breast cancer
lapatinib side effects
n/d, rash, can prolong QT interval, dehydration
sunitinib MOA
inhibits VEGFRalpha, beta, 1,2,3 and c-kit
sunitinib treats
kidney and pancreatic cancer
sunitinib side effects
diarrhea, HTN, bleeding complications, CYP3A4